COMMUNIQUÉS West-GlobeNewswire

HMS to Present at Two Upcoming Investor Conferences
29/05/2019
IRVING, Texas, May 29, 2019 (GLOBE NEWSWIRE) -- HMS Holdings Corp. (Nasdaq: HMSY) today announced its management team will present at two upcoming investor conferences in early June. CFO Jeff Sherman will present at the [...]
TearClear Appoints Chief Scientific and Innovation Officer
29/05/2019
Industry Leader Srini Venkatesh, PhD, to drive TearClear’s scientific and R&D strategy Supports the next phase of development for its disruptive ophthalmic pharmaceutical platform ORANGE COUNTY, Calif., May 29, 2019 [...]
Kintai Therapeutics Announces Formation of World-Class Scientific Advisory Board
29/05/2019
CAMBRIDGE, Mass., May 29, 2019 (GLOBE NEWSWIRE) -- Kintai Therapeutics, a Flagship Pioneering company developing precision therapeutics based on enteric signaling networks, today announced the formation of the Kintai [...]
BioSyent Releases Results for Q1 2019
29/05/2019
TORONTO, May 29, 2019 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, TSX Venture: RX) released today a summary of its financial results for the three months ended March 31, 2019. Key highlights include: First quarter ( [...]
The Joint Corp. to Host Investor Day on Monday, June 3
29/05/2019
SCOTTSDALE, Ariz., May 29, 2019 (GLOBE NEWSWIRE) -- The Joint Corp. (NASDAQ: JYNT), a national operator, manager and franchisor of chiropractic clinics, announced it will hold an investor day on Monday, June 3, 2019. At [...]
CareDx Announces KidneyCare and Showcases Leadership in Transplantation at ATC
29/05/2019
CareDx leadership in transplant innovation highlighted through 12 podium and poster presentations BRISBANE, Calif., May 29, 2019 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA), a leading molecular diagnostics company [...]
Wellness Matrix Group Appoints David Saltrelli Vice President of Marketing
29/05/2019
LOS ANGELES, May 29, 2019 (GLOBE NEWSWIRE) -- Wellness Matrix Group, Inc. (WMGR) announced today that branding, incentives, marketing, and sales expert David Saltrelli was appointed Vice President of Marketing. [...]
Akari Therapeutics Reports First Quarter 2019 Financial Results And Highlights Recent Clinical Progress
29/05/2019
Positive initial clinical data reported in ongoing bullous pemphigoid (BP) and atopic keratoconjunctivitis (AKC) clinical trials Further clinical data from BP and AKC trials anticipated in 2019 Pivotal clinical trial [...]
Albireo to Present at Investor Conferences in June
29/05/2019
BOSTON, May 29, 2019 (GLOBE NEWSWIRE) -- Albireo Pharma, Inc. (Nasdaq: ALBO), a clinical-stage orphan pediatric liver disease company developing novel bile acid modulators, today announced that Ron Cooper, President and [...]
Metacrine Reports Positive Interim Results with Sustained FXR Agonist in NASH Patients
29/05/2019
MET409, a non-bile acid sustained FXR agonist, showed no change in LDL cholesterol, no pruritis and favorable trends in liver fat reduction SAN DIEGO, May 29, 2019 (GLOBE NEWSWIRE) -- Metacrine, Inc., a clinical-stage [...]
Kiadis Pharma's Extraordinary General Meeting of Shareholders Approves CytoSen Acquisition
29/05/2019
Amsterdam, The Netherlands, May 29, 2019 - Kiadis Pharma N.V. ("Kiadis Pharma" or the "Company") (Euronext Amsterdam and Brussels: KDS), a clinical stage biopharmaceutical company, today announces that at its [...]
ESPERITE (ESP) announces termination of MoU regarding proposed sale of stem cell banking business to PBKM due to lack of agreement on the terms of the sale
29/05/2019
Amsterdam, The Netherlands – 29 May 2019 Esperite N.V. (Euronext: ESP, “Esperite”) announces today that the Memorandum of Understanding (MoU) between Esperite and Polski Bank Komórek Macierzystych S.A. (WSE: PBKM, “PBKM [...]
Nawal Ouzren and Heinz Maeusli appointed to Inventiva’s Board of Directors
29/05/2019
Nawal Ouzren and Heinz Maeusli appointed to Inventiva’s Board of Directors Daix (France), May 29, 2019 – Inventiva (Euronext: IVA), a clinical-stage biopharmaceutical company developing oral small molecule therapies for [...]
Nawal Ouzren et Heinz Maeusli nommés au Conseil d'Administration d'Inventiva
29/05/2019
Nawal Ouzren et Heinz Maeusli nommés au Conseil d'Administration d'Inventiva Daix (France), le 29 mai 2019 – Inventiva (Euronext : IVA), société biopharmaceutique spécialisée dans le développement clinique de petites [...]
NeuroSearch to implement reverse share split of all shares at consolidation ratio 20:1
29/05/2019
Company announcement 29 May 2019 At the annual general meeting of NeuroSearch A/S (the " Company ") on Monday 29 April 2019, the shareholders resolved to perform a consolidation of shares in the Company by means of a [...]
Saniona publishes its interim report for the first quarter 2019
29/05/2019
PRESS RELEASE May 29, 2019 Financial highlights Q1 2019 (Q1 2018) Net revenues were SEK 1.7 M (4.3 M) EBIT was SEK -29.1 M (-15.7 M) Net profit/loss was SEK -24.8 M (-13.5) Earnings per share were SEK -1.06 (-0.62) [...]
Biocartis Group NV: Disclosure of transparency notifications
29/05/2019
PRESS RELEASE: REGULATED INFORMATION 29 May 2019, 07:00 CEST Disclosure of transparency notifications Mechelen, Belgium, 29 May 2019 - Biocartis Group NV (the 'Company' or 'Biocartis'), an innovative molecular [...]
Bone Therapeutics SA: Information on the total number of voting rights and shares
29/05/2019
Regulated information Gosselies, Belgium, 29 May 2019, 7am CEST – BONE THERAPEUTICS (Euronext Brussels and Paris: BOTHE), the bone cell therapy company addressing high unmet medical needs in orthopaedics and bone [...]
Bone Therapeutics SA : Information relative au nombre total de droits de vote et d’actions
29/05/2019
Information réglementée Gosselies, Belgique, le 29 mai 2019, 07h00 CEST - BONE THERAPEUTICS (code Euronext Bruxelles et Paris : BOTHE), société de thérapie cellulaire osseuse qui répond à d’importants besoins médicaux [...]

Pages